Brighter Base Duo
Take 15% off this derm-approved AM duo for added radiance and a seamless base. Our gentle yet potent Vitamin C delivers brighter-looking skin over time, while new Ceramide Prime Whipped Cream delivers just-right hydration that wears beautifully under makeup.
Benefits
-
Brightens
-
Hydrates
-
Smooths
Brighter Base Duo
A duo for easier makeup days—and better bare-faced ones, too.
A duo for easier makeup days—and better bare-faced ones, too.
-
Do No Harm
Good to KnowDetails -
Do No Harm
Good to KnowDetails -
Ingredients
15% Tetrahexyldecyl Ascorbate in Brighten + Firm Vitamin C2% Tetrapeptide Solution in Brighten + Firm Vitamin C1% Ceramide Complex in Ceramide Prime Whipped Cream2% Niacinamide in Ceramide Prime Whipped CreamFull Ingredients
-
Ingredients
15% Tetrahexyldecyl Ascorbate in Brighten + Firm Vitamin C2% Tetrapeptide Solution in Brighten + Firm Vitamin C1% Ceramide Complex in Ceramide Prime Whipped Cream2% Niacinamide in Ceramide Prime Whipped CreamFull Ingredients
-
How to Use
Day + Night -
How to Use
Day + Night
-
Before
After
-
Before
After
Clinical Results
A clinically proven duo to deeply hydrate and significantly reduce the look of dark spots and fine lines.
Results of an 8 week clinical trial with 32 participants and 4-week clinical trial on 31 participants.
-
100% of Brighten + Firm Vitamin C Serum users saw their fine lines and wrinkles improved
Results of an 8 week clinical trial with 32 participants, analyzed with ImagePro® software. -
97% saw brighter and more naturally radiant skin, with no new discoloration over two months with Brighten + Firm Vitamin C Serum
Results of an 8-week consumer perception study with 32 participants, after 8 weeks. -
100% said their skin felt softer, bouncier, and more elastic after using Ceramide Prime for 4 weeks
Results of a 4-week clinical trial and consumer perception study on 31 participants. -
97% noticed their skin looked smoother, especially in texture-prone areas, after using Ceramide Prime 1 week.
Results of a 4-week consumer perception study and clinical trial on 31 participants.